OVID
NASDAQ · Biotechnology
Ovid Therapeutics Inc
$2.40
-0.14 (-5.51%)
Performance
1D
+0.00%
1W
-14.29%
1M
+10.60%
3M
-18.09%
6M
-1.64%
1Y
+84.62%
YTD
+36.36%
Open$2.52
Previous Close$2.54
Day High$2.66
Day Low$2.37
52W High$3.11
52W Low$1.18
Volume—
Avg Volume2.97M
Market Cap461.45M
P/E Ratio—
EPS$-0.25
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$2.50
Below
SMA 200
$2.42
Below
RSI (14)
54.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+1,610.0% upside
Current
$2.40
$2.40
Target
$41.04
$41.04
$30.97
$41.04 avg
$66.83
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.81M | 10.53M | 31.11M |
| Net Income | -42,742,890 | -22,750,370 | -8,350,078 |
| Profit Margin | -240.1% | -228.1% | -26.8% |
| EBITDA | -103,491,360 | -58,144,651 | -13,566,183 |
| Free Cash Flow | — | — | -8,976,737 |
| Rev Growth | +69.1% | +69.1% | +19.5% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.55 | -0.16% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $456.60 | -1.24% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $169.42 | +1.10% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $531.97 | -1.08% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $951.08 | -0.14% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $159.73 | -3.22% | 7.7 | 20.98B |